456 Studies Now Enrolling
Financial Distress during Treatment for Pediatric Acute Lymphoblastic Leukemia in theUnited States
Study of Financial Distress during Treatment for Pediatric Acute Lymphoblastic Leukemia (ALL)
| Sponsor: | NIH |
| Enrolling: | Male and Female Patients |
| IRB Number: | AAAU1676 |
| U.S. Govt. ID: | NCT04928599 |
| Contact: | Zvika Aloni: 000-000-0000 / za2277@cumc.columbia.edu |
Additional Study Information:
The purpose of this study is to learn about parents financial distress during their childs/adolescents treatment for Acute Lymphoblastic Leukemia (ALL). You can think of financial distress as worry or anxiety about money. The overall goals of this study are to measure parents financial distress during their childs/adolescents treatment for ALL and whether it changes over time; and, to learn what factors are associated with changes in financial distress.
This study is closed
Do You Qualify?
| Are you the parent of a child recently diagnosed with Acute Lymphoblastic Leukemia (ALL) and who is younger than 15 years old? | Yes | No |
| Is your child currently receiving their first line of chemotherapy for treatment of their ALL? | Yes | No |
| Are you willing to answer surveys and discuss potential financial hardships? | Yes | No |